文献速递产科母胎医学

妊娠期糖尿病远程患者监测与母婴结局改善相关

Remote patient monitoring for management of diabetes mellitus in pregnancy is associated with improved maternal and neonatal outcomes.
PubMed 文献 · Am J Obstet Gynecol · 2023-02-24

该回顾性队列研究纳入533例妊娠期糖尿病患者,比较远程患者监测(360例)与纸质血糖记录(173例)对母婴结局的影响。远程监测组血糖达标率更高(79.2% vs 52.0%,P<.0001)、达标时间更短(中位3.3周 vs 4.1周,P=.025),子痫前期(5.8% vs 15.0%,P=.0006)和新生儿低血糖(29.8% vs 51.7%,P<.0001)发生率更低,但复合母婴发病率无显著差异。

要点

  • 远程监测组血糖达标率79.2% vs 纸质组52.0%,P<.0001。
  • 远程监测组子痫前期发生率5.8% vs 纸质组15.0%,P=.0006。
  • 远程监测组新生儿低血糖发生率29.8% vs 纸质组51.7%,P<.0001。

核心结论

  • 妊娠期糖尿病远程患者监测在血糖控制方面优于传统纸质记录,并与母婴结局改善相关。

研究设计与样本

  • 回顾性队列研究,纳入2019年10月至2021年4月在一家学术机构母胎医学中心管理的533例妊娠期糖尿病患者。
  • 比较纸质血糖记录组173例与远程患者监测组360例(设备集成176例,手动录入184例)。

主要发现

  • 远程监测组与纸质组复合母体发病率和复合新生儿发病率均无显著差异。
  • 远程监测组上传血糖值更多(177 vs 146;P=.008),血糖达标率更高(79.2% vs 52.0%;P<.0001),达标时间更短(中位3.3周 vs 4.1周;P=.025)。
  • 远程监测组子痫前期发生率更低(5.8% vs 15.0%;P=.0006),新生儿出生后24小时内低血糖发生率更低(29.8% vs 51.7%;P<.0001)。
  • 远程监测组慢性高血压基线比例略高(6.1% vs 1.2%;P=.011),其余基线特征无显著差异。

临床怎么用

  • 原文结论认为,妊娠期糖尿病远程患者监测在血糖控制方面优于传统纸质记录,并与母婴结局改善相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetes mellitus is a common medical complication of pregnancy, and its treatment is complex. Recent years have seen an increase in the application of mobile health tools and advanced technologies, such as remote patient monitoring, with the aim of improving care for diabetes mellitus in pregnancy. Previous studies of these technologies for the treatment of diabetes in pregnancy have been small and have not clearly shown clinical benefit with implementation. OBJECTIVE: Remote patient monitoring allows clinicians to monitor patients' health data (such as glucose values) in near real-time, between office visits, to make timely adjustments to care. Our objective was to determine if using remote patient monitoring for the management of diabetes in pregnancy leads to an improvement in maternal and neonatal outcomes. STUDY DESIGN: This was a retrospective cohort study of pregnant patients with diabetes mellitus managed by the maternal-fetal medicine practice at one academic institution between October 2019 and April 2021. This practice transitioned from paper-based blood glucose logs to remote patient monitoring in February 2020. Remote patient monitoring options included (1) device integration with Bluetooth glucometers that automatically uploaded measured glucose values to the patient's Epic MyChart application or (2) manual entry in which patients manually logged their glucose readings into their MyChart application. Values in the MyChart application directly transferred to the patient's electronic health record for review and management by clinicians. In total, 533 patients were studied. We compared 173 patients managed with paper logs to 360 patients managed with remote patient monitoring (176 device integration and 184 manual entry). Our primary outcomes were composite maternal morbidity (which included third- and fourth-degree lacerations, chorioamnionitis, postpartum hemorrhage requiring transfusion, postpartum hysterectomy, wound infection or separation, venous thromboembolism, and maternal admission to the intensive care unit) and composite neonatal morbidity (which included umbilical cord pH <7.00, 5 minute Apgar score <7, respiratory morbidity, hyperbilirubinemia, meconium aspiration, intraventricular hemorrhage, necrotizing enterocolitis, sepsis, pneumonia, seizures, hypoxic ischemic encephalopathy, shoulder dystocia, trauma, brain or body cooling, and neonatal intensive care unit admission). Secondary outcomes were measures of glycemic control and the individual components of the primary composite outcomes. We also performed a secondary analysis in which the patients who used the two different remote patient monitoring options (device integration vs manual entry) were compared. Chi-square, Fisher's exact, 2-sample t, and Mann-Whitney tests were used to compare the groups. A result was considered statistically significant at P<.05. RESULTS: Maternal baseline characteristics were not significantly different between the remote patient monitoring and paper groups aside from a slightly higher baseline rate of chronic hypertension in the remote patient monitoring group (6.1% vs 1.2%; P=.011). The primary outcomes of composite maternal and composite neonatal morbidity were not significantly different between the groups. However, remote patient monitoring patients submitted more glucose values (177 vs 146; P=.008), were more likely to achieve glycemic control in target range (79.2% vs 52.0%; P<.0001), and achieved the target range sooner (median, 3.3 vs 4.1 weeks; P=.025) than patients managed with paper logs. This was achieved without increasing in-person visits. Remote patient monitoring patients had lower rates of preeclampsia (5.8% vs 15.0%; P=.0006) and their infants had lower rates of neonatal hypoglycemia in the first 24 hours of life (29.8% vs 51.7%; P<.0001). CONCLUSION: Remote patient monitoring for the management of diabetes mellitus in pregnancy is superior to a traditional paper-based approach in achieving glycemic control and is associated with improved maternal and neonatal outcomes.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kantorowska A, Cohen K, Oberlander M, et al. Remote patient monitoring for management of diabetes mellitus in pregnancy is associated with improved maternal and neonatal outcomes. Am J Obstet Gynecol. 2023. PMID: 36841348. doi:10.1016/j.ajog.2023.02.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。